Organogenesis Holdings (ORGO) Profit After Tax (2016 - 2026)
Organogenesis Holdings (ORGO) posted Profit After Tax of -$99.3 million for Q2 2026, down 76.89% on a QoQ basis from -$56.2 million in Q1 2026, and down 714.12% year-over-year from $16.2 million in Q2 2025.
Analysis
Organogenesis Holdings (ORGO) Profit After Tax (2016 - 2026) Analysis & Trends
Organogenesis Holdings has reported Profit After Tax for 11 years, with the latest figure at -$99.3 million in Q2 2026.
- On a quarterly basis, Profit After Tax fell 714.12% year-over-year to -$99.3 million in Q2 2026; TTM through Jun 2026 was -$81.8 million, a 424.79% decrease from a year earlier, with the FY2025 full-year figure at $37.0 million, up 4052.19% from the prior year.
- Profit After Tax was -$99.3 million for Q2 2026 at Organogenesis Holdings, down from -$56.2 million in the prior quarter.
- The five-year high for Profit After Tax was $52.1 million in Q4 2025, with the low at -$99.3 million in Q2 2026.
- Average Profit After Tax over 5 years is -$5.3 million, with a median of -$176500.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2025: Profit After Tax soared 1373.02% in 2023, then sank 928.14% in 2025.
- Over 5 years, Profit After Tax stood at $7.5 million in 2022, then slumped by 107.59% to -$568000.0 in 2023, then soared by 1134.33% to $5.9 million in 2024, then soared by 787.35% to $52.1 million in 2025, then tumbled by 290.55% to -$99.3 million in 2026.
- The last three Profit After Tax figures came in at -$99.3 million (Q2 2026), -$56.2 million (Q1 2026), and $52.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Organogenesis Holdings | 200.85 Mn | 154.00 Mn | 20.08 Mn | -99.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.34 Mn |
| Mar 31, 2026 | -56.16 Mn |
| Dec 31, 2025 | 52.13 Mn |
| Sep 30, 2025 | 21.57 Mn |
| Jun 30, 2025 | -12.20 Mn |
| Mar 31, 2025 | -21.59 Mn |
| Dec 31, 2024 | 5.88 Mn |
| Sep 30, 2024 | 12.33 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Mar 31, 2024 | -2.10 Mn |
| Dec 31, 2023 | -568,000.00 |
| Sep 30, 2023 | 3.17 Mn |
| Jun 30, 2023 | 5.32 Mn |
| Mar 31, 2023 | -2.97 Mn |
| Dec 31, 2022 | 7.49 Mn |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 8.74 Mn |
| Mar 31, 2022 | -913,000.00 |
| Dec 31, 2021 | 51.00 Mn |
| Sep 30, 2021 | 12.58 Mn |